Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Jette Wypych"'
Autor:
Banghua Sun, Wei Fan, Aldona Balciunas, Jillian K. Cooper, Gal Bitan, Shirley Steavenson, Paul E. Denis, Yunjen Young, Beverly Adler, Larry Daugherty, Raffi Manoukian, Gary Elliott, Wenyan Shen, Jane Talvenheimo, David B. Teplow, Mitsuru Haniu, Raj Haldankar, Jette Wypych, Christopher A. Ross, Martin Citron, William G. Richards
Publikováno v:
Neurobiology of Disease, Vol 11, Iss 1, Pp 111-122 (2002)
Amino-terminal fragments of huntingtin, which contain the expanded polyglutamine repeat, have been proposed to contribute to the pathology of Huntington's disease (HD). Data supporting this claim have been generated from patients with HD in which tru
Externí odkaz:
https://doaj.org/article/26fbad44ea784ee88e89c01dad9e7cb5
Autor:
Diandra Martinez-Cano, Rashmi Ravichandran, Huong Le, H. Edward Wong, Bharat Jagannathan, Erik J. Liu, William Bailey, Jane Yang, Kelli Matthies, Hedieh Barkhordarian, Bhavana Shah, Nithya Srinivasan, Jun Zhang, Angel Hsu, Jette Wypych, Jennitte Stevens, Deirdre Murphy Piedmonte, Les P. Miranda, Lauren Carter, Michael Murphy, Neil P. King, Neil Soice
Publikováno v:
Process Biochemistry. 129:241-256
Autor:
Yasser Nashed-Samuel, Jeremy Gastwirt, Ruchi B. Kotia, Stephanie Moore, Peter Masatani, Gianpiero Torraca, Monica Goss, David G. Dolan, Michael Akers, Chakradhar Padala, Jette Wypych, David J. Semin
Publikováno v:
Journal of Pharmaceutical Sciences. 111:3275-3286
A new type of lamellae-like particles was observed in protein based liquid therapeutic protein drug product (DP) packaged in standard (STD) and delamination controlled (DC) Type IB glass vials stored at 2-8°C as early as two weeks after manufacture.
Publikováno v:
Journal of Pharmaceutical Sciences.
Autor:
Bhavana Shah, Michael Ronk, Jian Liu, Kim Li, Yasser Nashed-Samuel, Zhongqi Zhang, Jason Richardson, Jette Wypych, Yanxin Luo, David J. Semin, Joel Perez-Pacheco, Ellen Jin
Publikováno v:
Journal of Pharmaceutical Sciences. 110:3794-3802
Battery-powered drug delivery devices are widely used as primary containers for storing and delivering therapeutic protein products to improve patient compliance and quality of life. Compared to conventional delivery approaches such as pre-filled syr
Publikováno v:
Journal of pharmaceutical sciences. 111(9)
Therapeutic IgG mAbs expressed from Chinese hamster ovary (CHO) cells are known to contain three C-terminal variants in their heavy chains, namely, the unprocessed C-terminal lysine, the processed C-terminal lysine, and C-terminal amidation. Although
Autor:
Laura E, Blue, Xiaoyan, Guan, Marisa K, Joubert, Scott T, Kuhns, Stephanie, Moore, David J, Semin, Mats, Wikström, Jette, Wypych, Chetan T, Goudar
Publikováno v:
Current Opinion in Biotechnology. 78:102800
The biopharmaceutical landscape continues to evolve rapidly, and associated modality complexity and the need to improve molecular understanding require concomitant advances in analytical approaches used to characterize and release the product. The Pr
Publikováno v:
mAbs
Disulfide linkage is critical to protein folding and structural stability. The location of disulfide linkages for antibodies is routinely discovered by comparing the chromatograms of the reduced and non-reduced peptide mapping with location identific
Publikováno v:
mAbs
Sequence variant analysis (SVA) is critical in therapeutic protein development because it ensures the absence of genetic mutations of a production clone or high-level misincorporations during cell culture. While software for searching sequence varian
Autor:
Quanzhou Luo, Kenneth W. Walker, Qing Chen, Kannan Gunasekaran, Riki Stevenson, Jie Wen, Frederick W. Jacobsen, Shu-Yin Ho, Lynette Buck, Linda O. Narhi, Kristine M. Daris, Wei Wang, Jette Wypych, Hossein Salimi-Moosavi, Sterling Miller, Ling Liu, Cynthia Li
Publikováno v:
Journal of Biological Chemistry. 292:1865-1875
IgG isotypes can differentially bind to Fcγ receptors and complement, making the selection of which isotype to pursue for development of a particular therapeutic antibody important in determining the safety and efficacy of the drug. IgG2 and IgG4 is